Steno Diabetes Center Zealand
- Address
- lock Available on a paid plan
Digestive System Diseases and Nutritional and Metabolic Diseases
At Steno Diabetes Center Zealand, clinical research in these areas focuses on bile acid diarrhoea (BAD) and related metabolic health concerns. The trials are designed to evaluate whether new treatment approaches can improve symptom control and patient outcomes.
- Testing a new treatment option for bile acid diarrhoea
- Assessing symptom relief, especially stool consistency response
- Comparing active therapy with placebo to understand treatment benefit
This work supports better care for patients living with digestive symptoms linked to metabolic disease, while also helping clarify how effective and safe emerging therapies may be.
Musculoskeletal Diseases and Nervous System Diseases
Research at this site also includes studies in diabetic acute Charcot foot, a serious complication affecting the bones and joints in people with diabetes. The goal is to determine whether a new therapy can improve recovery and reduce the impact of this condition.
- Evaluating treatment for acute Charcot neuroarthropathy
- Studying clinical outcomes in people with diabetic foot complications
- Exploring whether a targeted therapy can improve healing and function
These trials reflect a strong interest in diabetes-related complications, combining musculoskeletal and broader neurological aspects of disease management.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
- 1Cosmo Technologies Limited1active
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 111 other sites in Denmark
Therapeutic Area Benchmark — Denmark
Select a therapeutic area to compare against other sites in Denmark.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Denmark
Market Share
Country: Denmark
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Steno Diabetes Center Zealand
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety of Colesevelam Hydrochloride Modified-Release Tablets in Idiopathic Bile Acid Diarrhoea: A Randomized, Double-Blind, Placebo-Controlled Phase II Study | Cosmo Technologies Limited | Phase II | Recruiting | Sep 2025 | — |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| COLESEVELAM HYDROCHLORIDE | 1 | Unknown | 2025-09-18 | 2025-09-18 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.